FIELD: medicine.
SUBSTANCE: content of C-reactive protein is determined. If concentration of C-reactive protein is >0.131 g/l development of localised infection into generalised infection in patients with systemic inflammatory response is determined.
EFFECT: increased reliability of determining generalisation of infection in patients with acute myeloblastic leukemia in case of neutropenia.
1 ex, 2 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR DETECTION OF INFECTIOUS COMPLICATIONS IN PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKAEMIA ACCOMPANYING NEUTROPENIA | 2012 |
|
RU2497129C1 |
| METHOD FOR LABORATORY VERIFICATION OF INFECTIONS IN PATIENTS WITH ACUTE MANIFESTED MYELOID LEUKEMIA | 2011 |
|
RU2462711C1 |
| METHOD FOR DETERMINING HEMOSTASIS CRITERIA FOR PREDICTING UNFAVORABLE SEPSIS OUTCOME IN ACUTE MYELOBLASTOSIS CASES | 2006 |
|
RU2320996C1 |
| METHOD OF PREDICTING INFECTION DEVELOPMENT IN PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKAEMIA AT CHEMOTHERAPY BACKGROUND | 2014 |
|
RU2550967C1 |
| DIAGNOSTIC TECHNIQUE FOR INFECTION IN PATIENTS WITH MANIFESTED ACUTE LYMPHOBLASTIC LEUKAEMIA | 2013 |
|
RU2535057C1 |
| METHOD FOR DEFINING EARLY PERIOD CRITERIA FOR DETECTING HYPERCOAGULATION SINGS IN TREATING ACUTE LEUCOSIS PATIENTS | 2002 |
|
RU2227301C2 |
| METHOD FOR DIFFERENTIAL DIAGNOSIS OF MULTISYSTEM INFLAMMATORY SYNDROME IN CHILDREN ASSOCIATED WITH SARS-CoV-2 | 2023 |
|
RU2816437C1 |
| METHOD FOR PROGNOSIS OF CHEMOTHERAPY INFECTIVE COMPLICATIONS | 2005 |
|
RU2294540C1 |
| METHOD FOR PREDICTION OF RISK OF DEVELOPING INFECTIOUS COMPLICATIONS IN PATIENTS WITH MALIGNANT LYMPHOPROLIFERATIVE DISEASES AND RECEIVING PROGRAM CHEMOTHERAPY | 2014 |
|
RU2587757C1 |
| METHOD OF TREATING SEPTIC SHOCK ACCOMPANIED WITH AGRANULOCYTOSIS | 2015 |
|
RU2604672C1 |
